Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:6.2.1.7 (
BAL
)
1,977
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
A loop ligated at both sides was made in the ilecoecal portion of rabbit intestine. As2O3 solution was infused into this loop and the blood circulating around this loop was collected from the cannulated vein. As2O3 content absorbed in blood as well as that remaining in this loop were determined. In control rabbits on no drugs, approx. 30% of As2O3 infused was absorbed into the blood in 60 minutes. However, in rabbits on parenteral dimercaprol (
BAL
) or thioctic acid (TA), the content of As2O3 absorbed into the blood decreased remarkably while the content of As2O3 remaining in the loop increased. On the other hand, even when
BAL
or TA were added directly into thip loop containing As2O3, the content of As2O3 absorbed in blood decreased markedly, compared with that of the control group. Thus it was demonstrated that
BAL
or TA combined with
AsO3
(3-) after being excreted into the intestinal tract from the bile-duct, bringing about inhibition of the enteral absorption of As2O3.
...
PMID:[Metabolism of arsenic (15). Influence of arsenic antidotes on intestinal absorption of arsenic trioxide]. 110 20
1.
Arsenite
and arsenate poisoned rats were treated with either
BAL
(2,3-dimercapto-1-propanol), penicillamine (PA) (beta-beta dimethyl cystein) or selenium (Se) (as sodium selenite). 2. The minimal dose of each antagonist that treated arsenic-induced lethality (causing 100% survival) was the same for both arsenite and arsenate. 3. Arsenic mobilization from the tissues (blood, kidney, liver, lungs, spleen, muscles, brain, heart) and its excretion in urine and feces were higher in arsenite-intoxicated animals than in arsenate-intoxicated ones. 4. The effect of each antagonist, when injected alone, on the urinary and fecal excretion of endogenous metals (Cu, Zn, Fe, Ca and Mg) was also examined. 5. The results indicated marked differences in the relative ability of
BAL
, PA and Se to increase the excretion of the metals.
...
PMID:Effect of some arsenic antagonists on the toxicity, distribution and excretion of arsenite and arsenate in rats. 168 7
The effect of the chelating agent dimercaprol (
BAL
) on the embryotoxic and teratogenic effects of arsenite (As3+) was determined.
BAL
(sc, 30 mg/kg) was administered to pregnant CD-1 mice, either 8 and 4 hr prior to or 4 and 8 hr after a 12-mg/kg ip dose of arsenite; other females received a single sc injection of 60 mg/kg
BAL
concurrently with the arsenite. Treatments were given on Gestation Day 9 or 12 (copulation plug = Day 1). Controls received sc corn oil or ip H2O, with or without arsenite or
BAL
.
Arsenite
treatment caused gross and skeletal malformations and prenatal deaths, while controls were unaffected. When
BAL
was given prior to arsenite on Day 9, incidences of prenatal mortality and skeletal malformation were significantly diminished, and on Day 12,
BAL
protected against fetocidal effects of arsenite when given concurrently with the arsenite. No other significant protective effects against arsenite toxicity were seen due to
BAL
; however, concurrent
BAL
treatment on Day 9 appeared to result in decreased fetal mortality and a decline in skeletal malformations.
BAL
given following arsenite on Day 9 afforded no significant protection against the arsenic, although an apparent decrease in gross and skeletal malformations was suggestive of such an effect. According to these results,
BAL
is unlikely to have a practical beneficial effect on the arsenite exposed conceptus, because it must be administered prior to the teratogen (or perhaps simultaneously with it) to be effective.
...
PMID:Evaluation of the effect of BAL (2,3-dimercaptopropanol) on arsenite-induced teratogenesis in mice. 671 May 6